CLINICAL ROLE OF F-18 FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY FOR DETECTION AND MANAGEMENT OF RENAL CELL CARCINOMA
- 1 September 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 166 (3) , 825-830
- https://doi.org/10.1016/s0022-5347(05)65845-4
Abstract
Conclusions FDG-PET accurately detected local disease spread and metastatic disease in patients with renal cell carcinoma and altered treatment in 40%. FDG-PET may have a role in the diagnostic evaluation of patients with renal cell carcinoma preoperatively and staging of metastatic disease.Keywords
This publication has 18 references indexed in Scilit:
- F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.European Journal of Cardio-Thoracic Surgery, 1999
- Resection of metastatic renal cell carcinoma.Journal of Clinical Oncology, 1998
- Pet scanning in head and neck oncology: A reviewHead & Neck, 1998
- Renal oncocytomasAbdominal Radiology, 1998
- Oncological applications of positron emission tomography with fluorine-18 fluorodeoxyglucoseEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Positron emission tomography in the detection and management of metastatic melanomaMelanoma Research, 1996
- Renal cell carcinoma: Clinical aspects, imaging diagnosis, and stagingSeminars in Roentgenology, 1995
- Expanding indications for conservative renal surgery in renal cell carcinomaUrology, 1994
- Renal cell carcinoma: Survival and prognostic factorsUrology, 1986
- Prognostic significance of morphologic parameters in renal cell carcinomaThe American Journal of Surgical Pathology, 1982